Ultrasound-integrated tight control in early psoriatic arthritis during adalimumab treatment.
Psoriatic arthritis (PsA) is a multi-faceted disease, challenging the rheumatologist both for its complex diagnostic and therapeutic aspects. The efficacy of TNF-blockers treatment might be verified by the new imaging devices such as ultrasonography (US) that has a great impact on the tight control during follow-up. Otherwise, specific guidelines for the routine use of US in PsA are still not well defined and often the management of the disease is based only on the evidence-based experience of clinicians. In a young patient affected by early PsA, we describe the rapid and sustained remission of the disease after adalimumab treatment, accompanied by the healing of synovitis and erosion, underlining the importance of early aggressive therapy and the positive role of US tight control in the follow-up period.